Belka C - Search Results

1

Hypoxia downregulates Ku70/80 expression in cervical carcinoma tumors.

Lara PC, Lloret M, Clavo B, Apolinario RM, Bordón E, Rey A, Falcón O, Alonso AR, Belka C. Lara PC, et al. Among authors: belka c. Radiother Oncol. 2008 Nov;89(2):222-6. doi: 10.1016/j.radonc.2008.07.018. Epub 2008 Aug 14. Radiother Oncol. 2008. PMID: 18706726

2

Increased cytotoxicity of ionizing radiation in combination with membrane-targeted apoptosis modulators involves downregulation of protein kinase B/Akt-mediated survival-signaling.

Handrick R, Rübel A, Faltin H, Eibl H, Belka C, Jendrossek V. Handrick R, et al. Among authors: belka c. Radiother Oncol. 2006 Aug;80(2):199-206. doi: 10.1016/j.radonc.2006.07.021. Epub 2006 Aug 17. Radiother Oncol. 2006. PMID: 16916558

3

Evidence-based radiation oncology: oesophagus.

Berger B, Belka C. Berger B, et al. Among authors: belka c. Radiother Oncol. 2009 Aug;92(2):276-90. doi: 10.1016/j.radonc.2009.02.019. Epub 2009 Apr 15. Radiother Oncol. 2009. PMID: 19375187 Review.

4

Impact of localized radiotherapy on blood immune cells counts and function in humans.

Belka C, Ottinger H, Kreuzfelder E, Weinmann M, Lindemann M, Lepple-Wienhues A, Budach W, Grosse-Wilde H, Bamberg M. Belka C, et al. Radiother Oncol. 1999 Feb;50(2):199-204. doi: 10.1016/s0167-8140(98)00130-3. Radiother Oncol. 1999. PMID: 10368044

5

Molecular requirements for the combined effects of TRAIL and ionising radiation.

Marini P, Jendrossek V, Durand E, Gruber C, Budach W, Belka C. Marini P, et al. Among authors: belka c. Radiother Oncol. 2003 Aug;68(2):189-98. doi: 10.1016/s0167-8140(03)00186-5. Radiother Oncol. 2003. PMID: 12972315

6

Array-based comparative gene expression analysis of tumor cells with increased apoptosis resistance after hypoxic selection.

Weinmann M, Belka C, Güner D, Goecke B, Müller I, Bamberg M, Jendrossek V. Weinmann M, et al. Among authors: belka c. Oncogene. 2005 Sep 1;24(38):5914-22. doi: 10.1038/sj.onc.1208748. Oncogene. 2005. PMID: 15897868

7

Treatment-outcome for synchronous head-and-neck and oesophageal squamous cell carcinoma.

Welz S, Schmid A, Hehr T, Schulze K, Feldmann HJ, Budach W, Bamberg M, Belka C. Welz S, et al. Among authors: belka c. Radiother Oncol. 2005 Dec;77(3):267-70. doi: 10.1016/j.radonc.2005.07.004. Epub 2005 Sep 9. Radiother Oncol. 2005. PMID: 16154220

8

Combined action of celecoxib and ionizing radiation in prostate cancer cells is independent of pro-apoptotic Bax.

Handrick R, Ganswindt U, Faltin H, Goecke B, Daniel PT, Budach W, Belka C, Jendrossek V. Handrick R, et al. Among authors: belka c. Radiother Oncol. 2009 Mar;90(3):413-21. doi: 10.1016/j.radonc.2008.10.021. Epub 2008 Nov 27. Radiother Oncol. 2009. PMID: 19038466

9

Therapeutic options for recurrent malignant glioma.

Niyazi M, Siefert A, Schwarz SB, Ganswindt U, Kreth FW, Tonn JC, Belka C. Niyazi M, et al. Among authors: belka c. Radiother Oncol. 2011 Jan;98(1):1-14. doi: 10.1016/j.radonc.2010.11.006. Epub 2010 Dec 13. Radiother Oncol. 2011. PMID: 21159396 Review.

10

FET-PET for malignant glioma treatment planning.

Niyazi M, Geisler J, Siefert A, Schwarz SB, Ganswindt U, Garny S, Schnell O, Suchorska B, Kreth FW, Tonn JC, Bartenstein P, la Fougère C, Belka C. Niyazi M, et al. Among authors: belka c. Radiother Oncol. 2011 Apr;99(1):44-8. doi: 10.1016/j.radonc.2011.03.001. Epub 2011 Mar 30. Radiother Oncol. 2011. PMID: 21458093

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

634 results

Search Page